HOME >> MEDICINE >> NEWS
Shire's DAYTRANA(TM) transdermal patch approved by FDA for treatment of ADHD

Philadelphia, PA, US and Basingstoke, UK -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the U.S. Food and Drug Administration (FDA) approved DAYTRANA (methylphenidate transdermal system), the first and only non-oral medication for the treatment of attention deficit hyperactivity disorder (ADHD). DAYTRANA, a once daily transdermal patch formulation of methylphenidate, will be available in 10 mg, 15 mg, 20 mg and 30 mg dosage strengths.

"The approval of DAYTRANA is important news for ADHD patients, their families and healthcare providers. In addition to being the only patch treatment for ADHD, it offers a convenient option to deliver medicine for those diagnosed with ADHD," said Shire Chief Executive Officer Matthew Emmens. "The addition of DAYTRANA to Shire's portfolio reaffirms our position as the market leader in ADHD."

Shire and Noven Pharmaceuticals, Inc. submitted an amended New Drug Application (NDA) for DAYTRANA to the FDA in June of last year. DAYTRANA is licensed globally to Shire by Noven and will be available in pharmacies in the U.S. in mid 2006.

The efficacy of DAYTRANA was established in two controlled clinical trials in children aged 6 to 12 years old with ADHD. DAYTRANA combines methylphenidate, a medication with a 50-year history of use, with Noven's patented DOT Matrix transdermal technology. This transdermal delivery system delivers medication directly through the skin into the bloodstream, and is designed to provide consistent, smooth drug release throughout the day. The patch is designed to stay on during the normal daily activities of a child, including swimming, exercising, and bathing. Because DAYTRANA is a patch, physicians can manage the duration of its effect and potential side effects by having the patient wear the patch for a shorter time period than the recommended 9 hour wear time on a given day. In clinical trials, wearing a DAYTRANA patch for 9 hours provided a duration of
'"/>

Contact: Matthew Cabrey, Shire
MCabrey@us.shire.com
484-595-8248
Porter Novelli
7-Apr-2006


Page: 1 2 3

Related medicine news :

1. Shires DAYTRANA, first patch medication for ADHD in children, now available in pharmacies
2. DAYTRANA (methylphenidate transdermal system) significant reduces ADHD symptoms
3. Positive study results for methylphenidate transdermal system
4. Positive study results for methylphenidate transdermal system
5. Four new us patents granted to Acrux for transdermal drug delivery
6. Novel catheter technique successfully patches holes in the heart
7. CankerMelts patches reduce pain and speed resolution of canker sores
8. Blood test predicts success of quitting smoking using the nicotine patch
9. Decent NHS care for older people still too patchy
10. Do testosterone patches help women with under-active pituitary glands?
11. Fentanyl patch safe and effective alternative to oral opioids for pediatric pain patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... , ... The Coro Medical official sweepstakes grand prize winner of the LIFEPAK ... a small, volunteer-only department in rural Mississippi, Livingston entered the national contest with the ... department with life-saving equipment of this caliber in Panola County. , “We are so ...
(Date:4/17/2019)... , ... April 17, 2019 , ... ... advice. However, recently, this reluctance appears to be changing. Whether because of demographic ... at least, probe their healthcare providers advice. , In the past, efforts to ...
(Date:4/17/2019)... ... 17, 2019 , ... Purple Biosciences today introduces Purple Tree®, ... was designed to lessen the negative effects of alcohol, so adults can lead ... and Amazon.com . , According to the Centers for Disease Control, ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... commercialization, has just released the second installment of their two-part white paper series ... The new white paper reviews some of the high-level changes to ...
(Date:4/17/2019)... ... April 17, 2019 , ... Tune in Wednesday, April 17, ... who overcame infertility and endometriosis with robotic surgery. Hosts Dr. Jonathan Zaidan, MD, ... surgery for patients and the impact robotic surgery can have on a woman’s fertility, ...
Breaking Medicine News(10 mins):
(Date:4/19/2019)... ... ... CBD Hacker , the definitive guide to the CBD industry, has ... the best sales from brands that CBD Hacker’s team has thoroughly reviewed and vetted ... items. And CBD Hacker has also partnered with several leading brands to share exclusive ...
(Date:4/18/2019)... ... April 18, 2019 , ... Mesmerize ... point-of-care, announces a new strategic partnership with Pharmacy Health Network (PHN), ... exclusive sales and marketing representatives for PHN. , Together, the two companies will ...
(Date:4/18/2019)... ... April 18, 2019 , ... KVC Kentucky will ... Tempur Sealy, at Fasig-Tipton horse farm on May 17, 2019 to raise funds ... of the Bluegrass, this elegant venue highlights Kentucky's stunning farmland, prized Thoroughbred horses ...
Breaking Medicine Technology:
Cached News: